Cargando…
Prognostic Relevance and In Vitro Targeting of Concomitant PTEN and p16 Deficiency in Chordomas
SIMPLE SUMMARY: Chordomas are rare malignant bone tumors that predominantly occur along the spine. The most frequent alterations include the loss of PTEN and p16 proteins. While both oncoproteins have been investigated as independent prognostic factors, in our chordoma cohort of 43 patients we were...
Autores principales: | Seeling, Carolin, Mosca, Elena, Mantel, Eva, Möller, Peter, Barth, Thomas F. E., Mellert, Kevin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093147/ https://www.ncbi.nlm.nih.gov/pubmed/37046638 http://dx.doi.org/10.3390/cancers15071977 |
Ejemplares similares
-
Molecular features and vulnerabilities of recurrent chordomas
por: Seeling, Carolin, et al.
Publicado: (2021) -
Deficiency of PTEN and CDKN2A Tumor-Suppressor Genes in Conventional and Chondroid Chordomas: Molecular Characteristics and Clinical Relevance
por: Yang, Chenlong, et al.
Publicado: (2020) -
Characterization of Three Novel H3F3A-mutated Giant Cell Tumor Cell Lines and Targeting of Their Wee1 Pathway
por: Lübbehüsen, Christoph, et al.
Publicado: (2019) -
HOXA7, HOXA9, and HOXA10 are differentially expressed in clival and sacral chordomas
por: Jäger, Daniela, et al.
Publicado: (2017) -
Combined PDGFR and HDAC Inhibition Overcomes PTEN Disruption in Chordoma
por: Lee, Dae-Hee, et al.
Publicado: (2015)